Correction: MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response

Di Roio A, Hubert M, Besson L, et al. MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response. J Immunother Cancer 2023;11:e007733. doi: 10.1136/jitc-2023-007733

In this article, the affiliations have been updated, Authors CC and CM-C have been designated as joint senior authors and the supplementary material has been updated.